MoneyWorks4Me

Colinz Laboratories - Quaterly Results

31 Jul 2026 Evaluate
A decrease in the sales to Rs. 12.41 millions was observed for the quarter ended June 2026. The sales stood at Rs. 15.66 millions during the similar quarter previous year.Net Profit witnessed a 1934.75% growth almost the double from Rs. 1.18 millions to Rs. 24.01  millions  of same quarter last year.The company reported a degrowth in operating Profit to 1.84 millions from 2.11 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 12.41 15.66 -20.75 12.41 15.66 -20.75 61.36 65.28 -6.00
Other Income 1.22 0.75 62.67 1.22 0.75 62.67 4.84 2.98 62.42
PBIDT 1.84 2.11 -12.80 1.84 2.11 -12.80 8.91 7.94 12.22
Interest 0.07 0.12 -41.67 0.07 0.12 -41.67 0.47 0.42 11.90
PBDT 29.40 1.99 1377.39 29.40 1.99 1377.39 8.44 7.52 12.23
Depreciation 0.39 0.39 0.00 0.39 0.39 0.00 1.56 1.31 19.08
PBT 29.01 1.60 1713.13 29.01 1.60 1713.13 6.88 6.21 10.79
TAX 5.00 0.42 1090.48 5.00 0.42 1090.48 1.75 1.23 42.28
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.15 -0.52 -71.15
PAT 24.01 1.18 1934.75 24.01 1.18 1934.75 5.13 4.98 3.01
Equity 25.19 25.19 0.00 25.19 25.19 0.00 25.19 25.19 0.00
PBIDTM(%) 14.83 13.47 10.04 14.83 13.47 10.04 14.52 12.16 19.39
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..